Isaly Samuel D (CIK 0001055949)

Latest company ownership

Shares held
6,149,377
Last filed at
Mar 28, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
5,379,349
Last filed at
Jun 27, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
4,416,446
Last filed at
Mar 17, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
KALA - KALA BIO, Inc.
Role: 10% Owner
Shares held
2,692,715
Last filed at
Jan 12, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q3 2025Q4
Shares held
2,576,532
Last filed at
Nov 21, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
2,546,295
Last filed at
Oct 10, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q4 2025Q4
Shares held
1,469,524
Last filed at
Feb 21, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q1 2025Q4
Shares held
817,000
Last filed at
Feb 14, 2013
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q4 2025Q4
Shares held
708,201
Last filed at
Jun 29, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
564,780
Last filed at
May 13, 2016
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
49,270
Last filed at
Jan 4, 2018
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q3 2025Q4
GKOS - GLAUKOS Corp
Role: Director
Shares held
7,895
Last filed at
Sep 5, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2015Q2 2025Q4
AMRN - AMARIN CORP PLC\UK
Role: Director
Shares held
5,700
Last filed at
Sep 5, 2012
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 10, 2018 Jan 12, 2018 KALA BIO, Inc. 10% Owner Buy 95.0 +240,484 9.81% ✗ $3.2M
Jan 3, 2018 Jan 4, 2018 PALVELLA THERAPEUTICS, INC. 10% Owner Sell 15.0 -1,709,620 -23.55% ✗ $12.6M
Dec 18, 2017 Dec 20, 2017 PALVELLA THERAPEUTICS, INC. 10% Owner Sell 20.0 -147,635 -1.99% ✗ $841.5K
Nov 21, 2017 Nov 21, 2017 scPharmaceuticals Inc. 10% Owner Buy 100.0 +833,333 32.34% ✗ $11.7M
Oct 10, 2017 Oct 10, 2017 RHYTHM PHARMACEUTICALS, INC. 10% Owner Buy 100.0 +355,000 13.94% ✗ $6M
Aug 31, 2017 Sep 5, 2017 GLAUKOS Corp Director Sell 15.0 -580,200 -9.62% ✗ $22.5M
Aug 15, 2017 Aug 17, 2017 GLAUKOS Corp Director Sell 15.0 -325,000 -6.38% ✗ $12.3M
Jul 25, 2017 Jul 27, 2017 KALA BIO, Inc. 10% Owner Buy 100.0 +319,333 15.53% ✗ $4.8M
Mar 27, 2017 Mar 28, 2017 Adaptimmune Therapeutics PLC Director Buy 100.0 +1,190,476 24.01% ✗ $5M
Mar 15, 2017 Mar 17, 2017 Whitehawk Therapeutics, Inc. Director Buy 100.0 +762,995 20.88% ✗ $3.8M
Mar 10, 2017 Mar 14, 2017 GLAUKOS Corp Director Sell 15.0 -382,538 -4.91% ✗ $17.3M
Mar 3, 2017 Mar 7, 2017 GLAUKOS Corp Director Sell 17.5 -55,772 -2.56% ✗ $2.6M
Feb 16, 2017 Feb 21, 2017 Spyre Therapeutics, Inc. 10% Owner Buy 92.5 +109,300 8.04% ✗ $563.9K
Aug 10, 2016 Aug 12, 2016 GLAUKOS Corp Director Sell 16.3 -292,938 -4.17% ✗ $9.9M
Aug 3, 2016 Aug 5, 2016 GLAUKOS Corp Director Sell 15.0 -425,000 -14.67% ✗ $13M
Jun 27, 2016 Jun 29, 2016 Cartesian Therapeutics, Inc. Director Buy 100.0 +550,000 42.54% ✗ $7.7M
Jun 27, 2016 Jun 29, 2016 Cartesian Therapeutics, Inc. Director Buy 100.0 +550,000 42.54% ✗ $7.7M
Jun 23, 2016 Jun 27, 2016 Corvus Pharmaceuticals, Inc. Director Buy 48.8 +1,000 0.02% ✗ $13K
Jun 17, 2016 Jun 21, 2016 Corvus Pharmaceuticals, Inc. Director Buy 75.0 +38,383 0.72% ✗ $489.2K
Jun 14, 2016 Jun 16, 2016 Corvus Pharmaceuticals, Inc. Director Buy 65.0 +20,000 0.38% ✗ $247K
Jun 9, 2016 Jun 13, 2016 Corvus Pharmaceuticals, Inc. Director Buy 75.0 +50,000 0.95% ✗ $648.1K
May 20, 2016 May 25, 2016 Adaptimmune Therapeutics PLC Director Buy 97.5 +1,712,400 6.11% ✗ $17.8M
May 20, 2016 May 24, 2016 Corvus Pharmaceuticals, Inc. Director Buy 60.0 +4,716 0.09% ✗ $61.7K
May 18, 2016 May 20, 2016 Corvus Pharmaceuticals, Inc. Director Buy 60.0 +6,800 0.13% ✗ $80K
May 11, 2016 May 13, 2016 Intellia Therapeutics, Inc. Director Buy 100.0 +250,000 10.36% ✗ $4.5M
Jul 6, 2015 Jul 8, 2015 PALVELLA THERAPEUTICS, INC. Director Buy 95.0 +500,000 7.40% ✗ $1.4M
Jun 30, 2015 Jun 30, 2015 GLAUKOS Corp Director Sell 40.0 -11,734 -0.40% ✗ $211.2K
Feb 12, 2013 Feb 14, 2013 SUPERNUS PHARMACEUTICALS, INC. 10% Owner Sell 17.5 -302,183 -4.68% ✗ $2.3M
Dec 17, 2012 Dec 19, 2012 SUPERNUS PHARMACEUTICALS, INC. 10% Owner Sell 17.5 -297,815 -100.00% ✗ $2.1M
Sep 4, 2012 Sep 5, 2012 AMARIN CORP PLC\UK Director Sell 5.0 -233,700 -28.03% ✓ $3.4M
Jul 27, 2012 Jul 30, 2012 AMARIN CORP PLC\UK Director Sell 3.8 -366,300 -30.53% ✓ $5.4M
Jun 19, 2012 Jun 19, 2012 AMARIN CORP PLC\UK Director Sell 16.3 -617,100 -33.96% ✗ $8M